Deutsche Bank downgraded Tecan (TCHBF) to Hold from Buy with a price target of CHF 225, down from CHF 298. With 7%-8% of sales exposed to National Institutes of Health funding, Tecan appears particularly vulnerable to spending cuts, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCHBF:
